Vorasidenib Study in Pediatric Participants With Grade 2 Astrocytoma or Oligodendroglioma With an IDH1 or IDH2 Mutation
Clinical trial NCT07286292 · RECRUITING
Trial details
- NCT number
- NCT07286292
- Sponsor
- Institut de Recherches Internationales Servier (I.R.I.S.)
- Status
- RECRUITING
- Phase
- Phase 2
- Study type
- INTERVENTIONAL
- Start date
- 2026-07-23
- Primary completion
- 2033-05-02
- Enrollment
- 10
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.